Invest with us

Invest in the Future of Robotics

Humanoid robotics is no longer science fiction. It’s a fast evolving, multi billion dollar industry poised to change the way we work, care, teach, and live. At MAXimuz Technology, we’re building intelligent, modular, and scalable humanoid robots backed by advanced AI systems including our proprietary Actualize AI Technology and NeuroCare platform.

This is your opportunity to get involved early in a movement that’s reshaping the future of robotics and AI in real-world environments.

Why Robotics, Why Now?

The Timing Has Never Been Better

  • The global robotics market is projected to reach $94.3 billion by 2029 (Fortune Business Insights)

  • Humanoid robot segment is estimated to grow to $38+ billion by 2035 (Goldman Sachs, 2023)

  • Nearly 60% of healthcare institutions are already exploring robotics for caregiving and elderly support (PwC Health Research Institute)

  • AI-integrated robotics adoption in education and training is growing at 25% CAGR (HolonIQ, 2024)

Robotics is becoming essential infrastructure — not just for industry, but for society.

The MAXimuz Difference

Solving Real Problems with Real Technology

At MAXimuz, our competitive edge is clear: We’re not just creating hardware we’re integrating smart software ecosystems that unlock true humanoid intelligence.

Actualize AI Technology (AAIT)

A powerful AI engine that allows humanoid robots to learn from their environment in real-time using camera vision, motion feedback, and sensor fusion. With closed-loop machine learning, our robots don’t just execute commands they adapt, analyze, and improve over time.

MAXimuz NeuroCare

A specialized AI suite designed for healthcare and emotional support applications, enabling robots to assist with elderly care, patient interaction, cognitive stimulation, and wellness tracking. This system combines AI, data analytics, and human behavior modeling to make care more personal and proactive.

Our Modular, Scalable Approach

Hardware That Grows with Purpose

  • Tiered Robot Models: From entry-level to advanced configurations with swappable sensors, cameras, and modules.

  • Cross-Industry Applications: Tailored software solutions for education, healthcare, hospitality, retail, events, and more.

  • Human-Centered Design: Built to interact safely and naturally in real environments, alongside people.

MAXimuz robots are not built to impress they’re built to serve, scale, and solve.

Why Invest in MAXimuz Technology?

Positioned for Sustainable Growth

  • Led by Robotics Veterans: Over 25 years of leadership and implementation in emerging technologies

  • Global-Ready Strategy: Focused on key growth regions including Asia, the Middle East, and Oceania

  • IP-Driven Advantage: Proprietary systems like AAIT and NeuroCare create high barriers to entry

We’re building not just a company but a full robotics ecosystem that spans hardware, software, services, and education.

Awareness Over Urgency

This Isn’t a Pitch. It’s Perspective.

We’re not raising alarms or chasing headlines. Instead, we’re offering a grounded, forward-looking view into the future of robotics and inviting those with a long-term mindset to explore what we’re building.

This is your chance to:

  • Get ahead of one of the most transformational shifts of this decade

  • Partner with a robotics company that values purpose as much as performance

  • Co-create long-term value in a tech segment that’s just getting started

References

  1. McKinsey Global Institute – The Future of Work After COVID-19 (2021)

  2. Goldman Sachs – Humanoid Robots: AI’s Next Frontier (2023)

  3. Fortune Business Insights – Robotics Market Size Report (2024)

  4. PwC Health Research Institute – Top Health Industry Issues of 2025

  5. HolonIQ – Global EdTech Market Outlook (2024) our team will get back to you!

Let’s Begin a Thoughtful Conversation

Get in touch with our team to learn more and get insights about the future opportunities with Humanoid Robotics scroll down to complete the form.

A surge in Humanoid Robotics Investments

Over the past five years, investments in humanoid robotics have skyrocketed, especially since 2022, signaling a major shift from experimental concepts to commercially viable platforms.

Companies like Figure AI, 1X Technologies, Neura Robotics, and Unitree have raised massive funding rounds, with Figure AI alone securing $675 million in 2024.

The first quarter of 2025 set a new record, reaching $2.26 billion in global funding driven by significant Series B rounds such as Beyond Imagination’s $100 million, and with 61% of this capital coming from the Americas.

This surge reflects not only investor confidence in general-purpose humanoids but also growing interest from governments and tech giants aiming to shape the future of automation, labor, and smart city infrastructure.

Overview of humanoid robotics investments

Key Investment Rounds (2019–2025)

*Total yearly figures are indicative - limited specific public breakdowns by year.

Investment Trends & Patterns

Interpretation

  • General‑purpose humanoid robotics has shifted from sci‑fi to serious venture grade business with investments growing from seed stages to massive Series B’s.

  • Corporate & sovereign interest (e.g., Ray Kurzweil’s Beyond Imagination, Saudi, China funds) signals both technological promise and strategic positioning. Crunchbase News+4Wikipedia+4Crunchbase News+4Reuters

  • Regional leadership remains in the U.S., with Asia (China, South Korea, Japan) rising fast thanks to both private and public funding.

Here is a line chart illustrating the rise in humanoid robotics investments from 2020 to Q1 of 2025. As shown, funding has significantly accelerated in the last two years, with a steep jump in 2025 Q1 alone, reflecting the sector's rapid momentum and growing investor confidence.

a line chart illustrating the rise in humanoid robotics investments from 2020 to Q1 of 2025. As shown, funding has significantly accelerated in the last two years, with a steep jump in 2025 Q1 alone
Funding rounds by leading humanoid robotics companies from 2023 to early 2025